Fennec Pharmaceuticals Inc. (FENC)
$7.10
$0.17
(2.45%)
As on 11-May-2026 16:00EDT
Market cap
$241 Mln
Revenue (TTM)
$45 Mln
P/E Ratio
--
P/B Ratio
6.8
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.7 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
20.3
-
Debt to Equity
--
-
Book Value
$1.2
-
EPS
$-0.4
-
Face value
--
-
Shares outstanding
34,712,756
10 Years Aggregate
CFO
$-91.54 Mln
EBITDA
$-110.71 Mln
Net Profit
$-111.57 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fennec Pharmaceuticals (FENC)
| -7.8 | 22.2 | -8.9 | 19.3 | -3.5 | 3.5 | 11.2 |
|
BSE Sensex*
| -11.9 | -3.9 | -11.5 | -6.2 | 6.4 | 8.7 | 11.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|
|
Fennec Pharmaceuticals (FENC)
| 21.8 | 16.9 | 118.2 | -40.9 | 14.8 | 1.7 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Fennec Pharmaceuticals (FENC)
|
7.1 | 240.6 | 45.4 | -10.3 | -7.6 | -70.4 | -- | 6.8 |
| 5.3 | 1,599.6 | 75.1 | -146.4 | -262.8 | -13.3 | -- | 1.7 | |
| 15.7 | 1,958.6 | 298.3 | 298.2 | 32.7 | 63.9 | 7.1 | 3.5 | |
| 6.5 | 340.5 | 0.0 | -35.1 | 131,201.1 | -71 | -- | 7.2 | |
| 15.3 | 154.9 | 0.0 | -7.8 | -- | -55.7 | -- | 31.1 | |
| 0.6 | 2.2 | 663.9 | -181.5 | -27.4 | -5.3 | -- | 0.2 | |
| 1.9 | 229.7 | 1.6 | -63.1 | -3,895.2 | -229.7 | -- | 5.5 | |
| 55.8 | 5,455.8 | 0.0 | -383.2 | -- | -40.4 | -- | 4.1 |
Shareholding Pattern
View DetailsAbout Fennec Pharmaceuticals (FENC)
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity... pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 Read more
-
CEO & Director
Mr. Rostislav Raykov
-
CEO & Director
Mr. Rostislav Raykov
-
Headquarters
Research Triangle Park, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Fennec Pharmaceuticals (FENC)
What is the current share price of Fennec Pharmaceuticals Inc (FENC) Today?
The share price of Fennec Pharmaceuticals Inc (FENC) is $7.10 (NASDAQ) as of 11-May-2026 16:00 EDT. Fennec Pharmaceuticals Inc (FENC) has given a return of -3.5% in the last 3 years.
What is the current PB & PE ratio of Fennec Pharmaceuticals Inc (FENC)?
Since, TTM earnings of Fennec Pharmaceuticals Inc (FENC) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-21.73
|
6.37
|
|
2024
|
-391.38
|
-29.06
|
|
2023
|
-18.88
|
-26.07
|
|
2022
|
-10.96
|
-97.16
|
|
2021
|
-6.65
|
7.25
|
What is the 52 Week High and Low of Fennec Pharmaceuticals Inc (FENC)?
The 52-week high and low of Fennec Pharmaceuticals Inc (FENC) are Rs 9.92 and Rs 5.65 as of 12-May-2026.
What is the market cap of Fennec Pharmaceuticals Inc (FENC)?
Fennec Pharmaceuticals Inc (FENC) has a market capitalisation of $ 241 Mln as on 11-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Fennec Pharmaceuticals Inc (FENC)?
Before investing in Fennec Pharmaceuticals Inc (FENC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.